Comparing pain relief methods after kidney surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of two different analgesic techniques, the erector spina plane block and the quadratus lumborum block, in providing pain relief for patients undergoing elective open nephrectomy. Participants will be randomly assigned to one of three groups: a control group receiving patient-controlled analgesia (PCA) with morphine, the erector spina plane block, or the quadratus lumborum block. After standard anesthesia induction and monitoring, pain levels and morphine consumption will be recorded for one day post-surgery to assess the efficacy of each method.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ASA 1-3
* open nephrectomy elective patients
* BMI\<35

Exclusion Criteria:

* ASA 4-5-6
* Laparoscopic nephrectomy
* infection at the block side
* coagulation disorder
* BMI\>35

Where it's running

• Kocaeli University Medical Faculty
  İzmit, Turkey (Türkiye) Recruiting
• Kocaeli University Medical Faculty
  Kocaeli, Turkey (Türkiye) Active not recruiting

Study contacts

• Study coordinator: zehra ipek Arslan AYDIN, Professor
• Email: zehraipek48@gmail.com
• Phone: 00905325011339

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Plasma DNA Methylation to Classify Kidney Masses Before Surgery

  This study tests a blood-based DNA methylation test to help distinguish malignant kidney cancers from benign kidney masses in adults who are planned for kidney surgery.

  Recruiting RenJi Hospital · Shanghai, Shanghai Municipality · NCT07874542

• Your Kidney Cancer Immunotherapy: How You Get It and If Labs Can Be At Home

  This study tests whether people with kidney cancer prefer intravenous or subcutaneous immunotherapy and whether at‑home lab draws plus telehealth visits before treatment are practical.

  Recruiting at 7 sites Phase 4 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07872553

• Intensified monitoring to personalize cabozantinib dosing in advanced kidney cancer

  We will test whether closer pharmacology-based monitoring helps people with advanced kidney cancer tolerate cabozantinib better while keeping its effect against the cancer.

  Recruiting Centro di Riferimento Oncologico - Aviano · Aviano, Pordenone · NCT07805122

• Who’s at high risk after RCC surgery? Real-world clues from French registry

  This study looks at real-world data from French RCC patients who had local or high-risk locally advanced disease to see how they do after surgery and how doctors decide on adjuvant treatment.

  Recruiting University Hospital, Bordeaux · Bordeaux · NCT07753343

• First-in-human test of HH160 in people with advanced solid tumors

  HH160 is being tested to see if it is safe and how it behaves in the body, to see if it has early signs of helping various advanced cancers in adults.

  Recruiting at 3 sites Phase 1 Huahui Health · Waratah, New South Wales and 2 other locations · NCT07623369

• Neoadjuvant HIF-2α inhibitor with or without PD-1 antibody for resectable clear cell kidney cancer

  This trial tests whether casdatifan alone or combined with zimberelimab can shrink tumors in people with resectable clear cell kidney cancer before surgery.

  Recruiting at 2 sites Phase 2 Dana-Farber Cancer Institute · Boston, Massachusetts and 2 other locations · NCT07397611

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.